Table 1 Patient demographics, clinical, and peri-operative characteristics
Patient demographics | (N = 59) |
|---|---|
Age (X ± SD [years]) | 65.1 ± 11.16 |
Age above 60 [(% of total]) | |
Males (n [% of total]) | 39 (66.1%) |
BMI (X ± SD [kg/m2]) | 2.2 ± 0.89 |
Race (% of total) | |
Caucasian | 84.7% |
Black | 5.1% |
Asian | 5.1% |
Other | 5.1% |
Anesthesia and surgery data | |
Duration of anesthesia (mean ± SD [min]) | 370.3 ± 91.72 |
Duration of surgery (mean ± SD [min]) | 257.8 ± 76.82 |
Coronary artery bypass surgery (n) | 31 |
Extracorporeal circulation (% of total; duration [X ± SD (min)] | 89%; 127.6 ± 58.2 |
Aortic-cross-clamp (% of total; duration [X ± SD (min)] | 86%; 87.9 ± 43.9 |
Mitral valvuloplasty and replacement (n) | 10 |
Aortic valvuloplasty and replacement (n) | 20 |
Aortic aneurysm repair (n) | 7 |
Others (n) | 4 |
Estimated Blood Loss (X ± SD [mL]) | 180.7 ± 216.39 |
Peri-operative management | |
Transfusions during surgery | |
Packed Red Blood Cells (mean [CI 95%] [mL]) | 94.8 (0;1200) |
Fresh Frozen Plasma (mean [CI 95%] [mL]) | 48.2 (0;750) |
Cell Server (mean [CI 95%] [mL]) | 640.8 (0;1350) |
Total crystalloid during surgery (X ± SD [mL]) | 1365.7 ± 544.08 |
Clinical Care 24 h post-surgery | |
Packed Red Blood Cells (mean [CI 95%] [mL]) | 21 (0;600) |
Fresh Frozen Plasma (mean [CI 95%] [mL]) | 0 (0;0) |
Corticosteroid Administration (% of total) | 10.2% |
Ketorolac Administration (% of total) | 3.4% |
Acetaminophen Administration (% of total) | 79.7% |
ASA Administration (% of total) | 72.9% |
APACHE scores during ICU stay (X ± SD) | |
1 h | 18.6 ± 5.96 |
24 h | 10.2 ± 5.72 |
48 h | 9.9 ± 5.57 |
Comorbidities | (% of total) |
|---|---|
CCI (median [95% CI]) | 4(1.6;2.4) |
Acute Coronary Syndrome | 15.25% |
Chronic heart failure | 15.25% |
Connective tissue disease (non-active) | 5.7% |
Cerebrovascular disease | 10.2% |
Type 2 diabetes | 37.3% |
AIDS | 1.6% |
COPD | 8.47% |
Leukemia/neoplasms | 0% |
Acquired Immunodeficiency Syndrome | 0% |
Outcomes | |
Mortality | 5.08% |